MedTrace Logo

Impact of Microvascular Inflammation on Kidney Allograft Outcome

NCT06496269 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2024-07-11

No results posted yet for this study

Summary

Graft microvascular inflammation poses a significant challenge to successful kidney transplantation due to its heterogeneous clinical presentation. There is a critical need to unravel the clinical significance of newly defined allograft microvascular inflammation phenotypes in the Banff 2022 classification and assess the implications of these new phenotypes on kidney transplant precision diagnostics and patient risk stratification.

Conditions

  • Transplant;Failure,Kidney
  • Kidney Transplant Rejection

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Paris Translational Research Center for Organ Transplantation

    lead OTHER

Principal Investigators

  • Alexandre Loupy · Paris Institute for Transplantation and Organ Regeneration

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States
  • France
  • Germany
  • Spain
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06496269 on ClinicalTrials.gov